Peptides, Pseudomonas aeruginosa, polysaccharides and lipopolysaccharides--players in the predicament of cystic fibrosis patients.
Pier
G B
GB
Channing Laboratory, Dept of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115-5804, USA. gpier@channing.harvard.edu
D000215:Acylation; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000494:pharmacology; D002352:Carrier Proteins / Q000378:metabolism / Q000494:pharmacology; D003550:Cystic Fibrosis / Q000382:microbiology*; D004352:Drug Resistance, Microbial; D029968:Escherichia coli Proteins; D006025:Glycosaminoglycans / Q000378:metabolism; D006801:Humans; D008050:Lipid A / Q000378:metabolism; D008070:Lipopolysaccharides / Q000737:chemistry / Q000378:metabolism; D008168:Lung / Q000382:microbiology*; D026901:Membrane Transport Proteins; D010455:Peptides; D011552:Pseudomonas Infections / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000378:metabolism / Q000472:pathogenicity*; D016601:RNA-Binding Proteins; D027981:Symporters; D014774:Virulence
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D002352:Carrier Proteins; D029968:Escherichia coli Proteins; D006025:Glycosaminoglycans; D008050:Lipid A; D008070:Lipopolysaccharides; D026901:Membrane Transport Proteins; D010455:Peptides; C079244:ProP protein, E coli; C118132:ProQ protein, E coli; D016601:RNA-Binding Proteins; D027981:Symporters; C046129:mucoid exopolysaccharide (P aeruginosa)